248 results on '"Bleakley, Marie"'
Search Results
2. HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation
3. Microbiota dictate T cell clonal selection to augment graft-versus-host disease after stem cell transplantation
4. qPCR assay for detection of Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Elements from CAR-T and TCR-T cells in fresh and formalin-fixed tissue
5. Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
6. Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy
7. Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML
8. Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Leukemia Remission Confers a Leukemia-Free Survival Advantage
9. CD19 occupancy may drive CARs further
10. CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia
11. Discovery of U2AF1 neoantigens in myeloid neoplasms
12. Short H2A histone variants are expressed in cancer
13. Role of chimeric antigen receptor T-cell therapy: bridge to transplantation or stand-alone therapy in pediatric acute lymphoblastic leukemia
14. Development of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse
15. Prognosis of relapse after hematopoietic cell transplant (HCT) for treatment of leukemia or myelodysplastic syndrome (MDS) in children
16. T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant
17. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
18. CCR Translation for the Article from Development of Tumor-Reactive T Cells After Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for Chronic Lymphocytic Leukemia
19. Revisiting Pre-Transplant Testicular Radiation for Relapse Prophylaxis in Allogeneic Hematopoietic Cell Transplantation (HCT) for Acute Lymphoblastic Leukemia (ALL)
20. Revisiting the Role of Post-Transplant Central Nervous System Prophylaxis in Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
21. Outcomes for Pediatric Myeloid Malignancy Patients Requiring Pediatric Intensive Care Unit (ICU) Admission Post-HCT
22. T-Cell Receptor–Based Immunotherapy for Hematologic Malignancies
23. Single-Cell Multiomics for Residual Disease Detection in Acute Myelogenous Leukemia after Allogeneic Hematopoietic Cell Transplantation
24. 93 PCR assay to identify woodchuck hepatitis virus posttranscriptional regulatory element in CAR-T and TCR-T cells for fresh and formalin-fixed samples
25. MDM2 inhibition augments GVL effect
26. Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Naïve T Cells and Retain Functional Pathogen-Specific Memory T Cells
27. Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease
28. Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo
29. Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen
30. Targeting an alternate Wilms’ tumor antigen 1 peptide bypasses immunoproteasome dependency
31. Zinc Status Affects T Cell Reconstitution after Transplant in Patients Receiving Naïve-T Cell Depleted Allo-Transplants
32. The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor
33. Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells
34. Outcomes of acute leukemia patients transplanted with naive T cell–depleted stem cell grafts
35. Future of allogeneic hematopoietic stem cell transplantation for chemotherapy-resistant pediatric acute leukemia: potential advances
36. Detection of engineered T cells in FFPE tissue by multiplex in situ hybridization and immunohistochemistry
37. Outcomes of Patients Undergoing Third Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies
38. Competencies required of health service managers in the 1990s
39. Phase I Study of Adoptive Immunotherapy with HA-1-Specific CD8+ and CD4+ Memory T Cells for Children and Adults with Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Trial in Progress
40. A Shared SF3B1 Neoantigen Is Presented on Primary Malignant Cells and Induced Pluripotent Stem Cell-Derived Hematopoietic Lines
41. Naive T-cell depletion in stem cell transplantation
42. 557 - Revisiting Pre-Transplant Testicular Radiation for Relapse Prophylaxis in Allogeneic Hematopoietic Cell Transplantation (HCT) for Acute Lymphoblastic Leukemia (ALL)
43. 559 - Revisiting the Role of Post-Transplant Central Nervous System Prophylaxis in Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
44. 169 - Outcomes for Pediatric Myeloid Malignancy Patients Requiring Pediatric Intensive Care Unit (ICU) Admission Post-HCT
45. Adoptive Transfer of Allogeneic Antigen-Specific T Cells
46. NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma
47. Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation
48. Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia
49. Minor Histocompatibility Antigen-Specific T Cells
50. T cell optimization for graft-versus-leukemia responses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.